Vaso-occlusion in sickle cell anemia: Role of interactions between blood cells and endothelium

Hematology Journal

Volumn 5, Issue SUPPL. 3, 2004, Pages

  Elion, Jacques E ^a   Brun, Manuel ^b   Odièvre, Marie Heléne ^b   Lapouméroulie, Claudine L ^b   Krishnamoorthy, Rajagopal ^b  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN; CD36 ANTIGEN; DEOXYHEMOGLOBIN; ENDOTHELIN 1; HYDROXYUREA; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; NITRIC OXIDE; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; BINDING AFFINITY; BLOOD CELL; BLOOD VESSEL OCCLUSION; BLOOD VESSEL TONE; CELL ACTIVITY; CELL ADHESION; CELL COUNT; CELL INTERACTION; GENE MUTATION; HUMAN; IN VITRO STUDY; NEUTROPHIL; PATHOPHYSIOLOGY; PROTEIN BINDING; PROTEIN EXPRESSION; SICKLE CELL ANEMIA; VASCULAR ENDOTHELIUM;

ANEMIA, SICKLE CELL; ARTERIAL OCCLUSIVE DISEASES; BLOOD PROTEINS; CELL ADHESION; CELL ADHESION MOLECULES; DRUG DESIGN; ENDOTHELIUM, VASCULAR; ERYTHROCYTES, ABNORMAL; HUMANS; HYDROXYUREA; NITRIC OXIDE; RETICULOCYTES;

EID: 4043083404     PISSN: 14664860     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.thj.6200452     Document Type: Article

References (20)

1. Bunn HF. Pathogenesis and treatment of sickle cell disease. N Engl J Med 1997; 337: 762-769.
2. Brugnara C. Cation homeostasis. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH (eds). Sickle Cell Disease. Basic Principles and Clinical Practice. Raven Press: New York, 1994.
3. Hofrichter J, Ross PD, Eaton WA. Kinetics and mechanism of deoxyhemoglobin S gelation: a new approach to understanding sickle cell disease. Proc Natl Acad Sci USA 1974; 71: 4864-4868.
4. Hoover R, Rubin R, Wise G, Warren R. Adhesion of normal and sickle erythrocytes to endothelial monolayer cultures. Blood 1979; 54: 872-876.
5. Hebbel RP, Yamada O, Moldow CF, Jacobs HS, White JJ, Eaton JW. Abnormal adherence of sickle erythrocytes to cultured vascular endothelium. Possible mechanism for microvascular occlusion in sickle cell disease. J Clin Invest 1980; 65: 154-160.
6. Hebbel RP. Adhesive interactions of sickle erythrocyte with endothelium. J Clin Invest 1997; 99: 2561-2564.
7. Joneckis CJ, Ackley RL, Orringer EP, Wayner EA, Parise LV. Integrin alpha4beta1 and glycoprotein IV(CD36) are expressed on circulating reticulocytes in sickle cell anemia. Blood 1993; 82: 3548-3555.
8. Browne PV, Hebbel RP. CD36-positive stress reticulocytosis in sickle cell anemia. J Lab Clin Med 1996; 127: 340-347.
9. Udani M, Zen Q, Cottman M, Leonard N, Jefferson S, Daymont C et al. Basal cell adhesion molecule/Lutheran protein. The receptor critical for sickle cell adhesion to laminin. J Clin Invest 1998; 101: 2550-2558.
10. El Nemer W, Gane P, Cohn Y, Bony V, Rahuel C, Galacteros F et al. The Lutheran blood group glycoproteins, the erythroid receptors for laminin, are adhesion molecules. J Biol Chem 1998; 273: 16686-16693.
11. Kaul DK, Nagel RL, Chen D, Tsai HM. Sickle erythrocyte-endothelial interactions in microcirculation : the role of von Willebrand factor and implications for vasoocclusion. Blood 1993; 81: 2429-2438.
12. Hofstra TC, Kalra VK, Meiselman HJ, Coates TD. Sickle erythrocytes adhere to polymorphonuclear neutrophils and activate the neutrophil respiratory burst. Blood 1996; 87: 4440-4447.
13. Okpala I, Daniel Y, Haynes R, Odoemene D, Goldman J. Relationship between the clinical manifestations of sickle cell disease and the expression of adhesion molecules on white blood cells. Eur J Haematol 2002; 69: 135-144.
14. Wun T, Paglieroni T, Tablin F, Welborn J, Nelson K, Cheung A. Platelet activation in platelet-erythrocyte aggregates in patients with sickle cell anemia. J Lab Clin Med 1997; 129: 507-516.
15. Solovey A, Lin Y, Browne P, Choong S, Wayner E, Hebbel RP. Activated endothelial cells in sickle cell anemia. N Engl J Med 1997; 337: 1584-1590.
16. Reiter CD, Wang X, Tanus-Santos JE, Hogg N, Cannon III RO, Schechter AN et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 2002; 8: 1383-1389.
17. Maier-Redelsperger M, Labie D, Elion J. Long-term hydroxyurea treatment in young sickle cell patients. Curr Opin Hematol 1999; 6: 115-120.
18. Styles L, Lubin B, Vichinsky E, Lawrence S, Hua M, Test S et al. Decrease of very late activation antigen-4 and CD36 on reticulocytes in sickle cell patients treated with hydroxyurea. Blood 1997; 89: 2554-2559.
19. Brun M, Bourdoulous S, Courot PO, Elion J, Krishnamoorthy R, Lapoumeroulie C. Hydroxyurea down regulates endothelin-1 gene expression and upregulates ICAM-1 gene expression in cultured human endothelial cells. Pharmacogenomics J 2003; 3: 215-226.
20. Benkerrou M, Delarche C, Brahimi L, Fay M, Vilmer E, Elion J et al. Hydroxyurea corrects the dysregulated L-selectin expression and increased H(2)O(2) production of polymorphonuclear neutrophils from patients with sickle cell anemia. Blood. 2002; 99: 2297-2303.